Amedisys Reports Fourth Quarter and Year End 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Amedisys (AMED) Misses Q4 EPS by 10c, Beats on Revenue
February 26, 2025 4:32 PM ESTAmedisys (NASDAQ: AMED) reported Q4 EPS of $0.96, $0.10 worse than the analyst estimate of $1.06. Revenue for the quarter came in at $598.1 million versus the consensus estimate of $596.76 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
... More